ArticleHaematologica2016

Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group.

Maria Winqvist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.